... The results showed that people with HIV were more likely to have chronic (long-term) conditions such as diabetes, high blood pressure, high cholesterol, and chronic kidney disease.Stroke was also seen more often in people with HIV. ...
Aging With HIV: 5 Problems To Watch For
... The results showed that people with HIV were more likely to have chronic (long-term) conditions such as diabetes, high blood pressure, high cholesterol, and chronic kidney disease.Stroke was also seen more often in people with HIV. ...
... Talk With Others Who UnderstandOn myHIVteam, the social network for people with HIV and their loved ones, more than 35,000 members come together to ask questions, give advice, and share their stories with others who understand life with HIV.Have you experienced dental problems while living with HIV? ...
6 Dental and Oral Problems With HIV
... Talk With Others Who UnderstandOn myHIVteam, the social network for people with HIV and their loved ones, more than 35,000 members come together to ask questions, give advice, and share their stories with others who understand life with HIV.Have you experienced dental problems while living with HIV? ...
... For example, semaglutide has been shown to improve heart and kidney health.Researchers are actively studying the safety and effectiveness of GLP-1 drugs in people living with HIV. Two ongoing clinical trials are exploring the effects of semaglutide in this population. ...
GLP-1 Drugs and HIV: Is It Safe To Take Them With Your Meds?
... For example, semaglutide has been shown to improve heart and kidney health.Researchers are actively studying the safety and effectiveness of GLP-1 drugs in people living with HIV. Two ongoing clinical trials are exploring the effects of semaglutide in this population. ...
... In the second study, participants switched from Biktarvy to the new tablet. Researchers found that: Switching worked about as well as staying on Biktarvy at 48 weeks. Viral rebound was uncommon in both groups (again, roughly 1 percent). What Side Effects Occurred? ...
... Although CBD is generally considered safe and well tolerated, it can lead to several adverse effects, such as: Dizziness Fatigue Sleepiness Diarrhea Sleep problems Drug InteractionsCBD can interact with other medications and supplements, reducing their effectiveness or increasing the risk of side effects. ...
CBD for HIV: Is It Effective?
... Although CBD is generally considered safe and well tolerated, it can lead to several adverse effects, such as: Dizziness Fatigue Sleepiness Diarrhea Sleep problems Drug InteractionsCBD can interact with other medications and supplements, reducing their effectiveness or increasing the risk of side effects. ...
"After years of feeling like I need to be better, stronger, healthier, and in control, I now kno...
... More people from these communities get infected with HIV and experience HIV-related health problems than those in other communities. HIV rates are higher in Black and Latino communities due to economic challenges, limited access to health care, and factors that affect how people seek help and learn about HIV prevention. ...
Race and HIV: Who Is Most Affected?
... More people from these communities get infected with HIV and experience HIV-related health problems than those in other communities. HIV rates are higher in Black and Latino communities due to economic challenges, limited access to health care, and factors that affect how people seek help and learn about HIV prevention. ...
... To help minimize these side effects, take Sustiva on an empty stomach and take Tivicay and Biktarvy in the morning.If you think your HIV treatments, such as ART drugs, are causing sleep problems or lowering your energy levels, talk to your doctor. ...
Fatigue and HIV: 6 Tips for Boosting Energy
... To help minimize these side effects, take Sustiva on an empty stomach and take Tivicay and Biktarvy in the morning.If you think your HIV treatments, such as ART drugs, are causing sleep problems or lowering your energy levels, talk to your doctor. ...
Join
Your Privacy Choices
